NCT07198789 Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia
| NCT ID | NCT07198789 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bologna |
| Condition | Cardiovascular Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-02-02 |
| Primary Completion | 2026-09-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-02-02 with a primary completion date of 2026-09-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Low-glycemic index (GI) carbohydrates help prevent type 2 diabetes and cardiovascular disease by reducing postprandial glucose, insulin spikes, inflammation, and triglyceride synthesis. They improve weight, lipid profiles, and vascular health. Our study will compare functional low-GI vs. standard wholegrain carbs in a Mediterranean diet to assess their effect on the Triglycerides-Glucose Index, a marker of metabolic and cardiovascular risk, in subjects with suboptimal triglyceride levels.
Eligibility Criteria
Inclusion Criteria: * Male or female aged ≥ 18 years * TG\>150 mg/dL * Subjects who have the capability to communicate and to comply with the study's requirements. * Subjects agree to participate in the study and having dated and signed the informed consent form. Exclusion Criteria: * Gluten hypersensitivity/Coeliac disease diagnosis * BMI\>30 kg/m2 * Any preventive treatments (i.e. lipid-lowering drugs, antihypertensives) not stabilized in type and dose for at least 3 months * Any medical or surgical condition that would limit the patient adhesion to the study protocol.
Frequently Asked Questions
Who can join the NCT07198789 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07198789 currently recruiting?
Yes, NCT07198789 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Bologna to inquire about joining.
Where is the NCT07198789 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT07198789 clinical trial?
NCT07198789 is sponsored by University of Bologna. The trial plans to enroll 40 participants.